Once-daily antiretroviral options

1 November 2002. Related: On the web.

STEP Perspective Volume 02, Number 2, Fall 2002
Lara Strick MD

Numerous studies have now shown that very high levels of adherence to medication regimens are necessary for adequate HIV suppression.

The ideal antiretroviral (ARV) regimen is simple, effective, and well tolerated. An increasing number of approved once-daily regimens are being used to minimise pill burden and optimise adherence. There is already data showing the efficacy of once-daily dosing of Videx, Epivir, Viread, Viramune, Sustiva, Fortovase/Norvir and Agenerase/Norvir.

Full text:
http://www.thebody.com/step/fall02/once_daily.html